APP and Alzheimer disease: The presentation concluded with new data showing that HIV-1 neuropathogenesis can be studied alongside Alzheimer’s disease in immunodeficient mice that combine transgenic expression of human IL-34 with modifications to the mouse amyloid precursor protein gene [29].